Fig. 1.

Of 1,025 subjects enrolled at 9 sites, there were 933 evaluable subjects (91.0%), from which we planned to collect 3,732 samples (933 subjects with 4 samples each). Of these, 382 (10.2%) samples were either missing or considered nonevaluable (expired). Of the 3,350 evaluable samples (738 urine, 877 vaginal swab, 922 endocervical swab, and 813 ThinPrep samples), 3,343 (99.8%) had final valid results; seven (0.2%; 3 urine, 2 vaginal swab, and 2 endocervical swab) samples had final invalid results and were not included in the analyses. ATV, Aptima T. vaginalis.